ACM
FENC icon

AIGH Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

AIGH Capital Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.7M Buy
2,486,038
+504,537
+25% +$4.12M 1.68% 11
2026
Q1 		$12.2M Buy
1,981,501
+400,000
+25% +$3.09M 1.66% 18
2025
Q4 		$12.2M Buy
1,581,501
+900,000
+132% +$7.39M 2.95% 12
2025
Q3 		$6.38M Buy
681,501
+229,101
+51% +$1.98M 1.8% 20
2025
Q2 		$3.75M Buy
452,400
+91,395
+25% +$625K 1.69% 22
2025
Q1 		$2.2M Buy
+361,005
New +$2.32M 0.91% 30
2024
Q2 		– Sell
-570,332
Closed -$6.34M – 43
2024
Q1 		$6.34M Buy
570,332
+240,962
+73% +$2.42M 1.9% 13
2023
Q4 		$3.7M Sell
329,370
-44,156
-12% -$366K 1.46% 27
2023
Q3 		$2.81M Buy
373,526
+24,069
+7% +$196K 1.33% 22
2023
Q2 		$3.09M Buy
349,457
+187,303
+116% +$1.56M 1.26% 21
2023
Q1 		$1.35M Buy
+162,154
New +$1.5M 0.5% 40

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PCM
Potomac Capital Management New York $147M AUM

AIGH Capital Management's FENC Position: Q2 2026 in Review

AIGH Capital Management increased its Fennec Pharmaceuticals (FENC) stake by 25% in Q2 2026, buying an estimated $4.12M and bringing the position to 2,486,038 shares worth $26.7M. The position accounts for 1.68% of the portfolio, ranked #11.

AIGH Capital Management first reported a position in FENC in Q1 2023 and has held it in 11 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • AIGH Capital Management held 2,486,038 shares of Fennec Pharmaceuticals worth $26.7M as of Q2 2026.
  • AIGH Capital Management bought 504,537 Fennec Pharmaceuticals shares in Q2 2026, an estimated $4.12M.
  • Fennec Pharmaceuticals made up 1.68% of AIGH Capital Management's portfolio in Q2 2026, its #11 holding.
  • AIGH Capital Management first reported a position in Fennec Pharmaceuticals in Q1 2023 and has held it in 11 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.